Table 3 Therapies instituted for the management of Arrhythmia (n = 42)
Therapy* | Frequency (%) |
|---|---|
Spontaneous termination (without therapy) | 2 (4.8) |
Acute therapy | |
Valsalva Manoeuvre | 2 (4.8) |
Cardioversion | 22 (52.4) |
Chemical (antiarrhythmic drugs) | 8 (36.4) |
Electrical | 14 (63.60) |
Defibrillation | 3 (4.8) |
Beta-blocker | 4 (9.5) |
Transvenous pacemaker implantation | 10 (23.8) |
CPR (for cardiac arrest) | 3 (7.1) |
Hyperkalaemia correction | 3 (7.1) |
Long term therapy | |
Antiarrhythmic drugs | 17 (40.5) |
Amiodarone | 13 (76.5) |
Flecainide | 1 (5.9) |
Beta-blocker | 3 (17.6) |
Mitral valve repair/replacement | 1 (2.4) |
Transvenous pacemaker implantation | 4 (9.5) |
Percutaneous coronary intervention | 3 (7.1) |
ICD implantation | 1 (2.4) |
ASD closure | 1 (2.4) |
Radiofrequency ablation | 2 (2.4) |
Heart failure management | 2 (2.4) |
Haemodialysis | 1 (2.4) |
Others | 10 (21.4) |
*One patient may be given more than one therapies during management of condition; patient may also receive a short-term and not be given a long-term therapy CPR = cardiopulmonary resuscitation; ICD = implantable cardioverter defibrillator; ASD = atrial septal defect | |